Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications
Clinical trial NCT00097786 · COMPLETED
Trial details
- NCT number
- NCT00097786
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2009-10-01
- Enrollment
- 9306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.